Wolverine Trading, LLC Iveric Bio, Inc. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 23, 2023	SELL	$26.24 - $39.63 $26,240 - $39,630	-1,000 Reduced 6.41%	14,600 $574,000
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $67,212 - $88,416	3,600 Added 30.0%	15,600 $371,000
Q4 2022 Feb 14, 2023	SELL	$17.24 - $23.95 $568,920 - $790,350	-33,000 Reduced 73.33%	12,000 $257,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $125,020 - $247,247	13,300 Added 41.96%	45,000 $779,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $289,104 - $599,130	31,700 New	31,700 $307,000
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $502,029 - $681,714	-36,300 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $256,641 - $635,250	36,300 New	36,300 $563,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.